2024-12-03 - Analysis Report
## Starbucks Corp (SBUX) Stock Report

**1. Performance Comparison and Divergence:**

Starbucks Corp (SBUX), a global coffeehouse chain, has accumulated a return of 71.75% compared to the S&P 500's (VOO) return of 130.06%.  This represents a final divergence of -58.3 percentage points. The relative divergence of -24.7% indicates SBUX's performance is below the S&P 500, placing it in the lower quartile of its historical performance relative to the index.


**2. Recent Price Movements:**

* **Closing Price:** $102.46
* **5-Day Moving Average:** $101.80
* **20-Day Moving Average:** $98.97
* **60-Day Moving Average:** $96.75

The price is above all three moving averages, suggesting a potential short-term uptrend.  The last market price of $101.47 is not significantly different from the closing price. No significant recent price spikes (rapid increases or decreases) are evident based on the provided data.


**3. Technical Indicators and Expected Return:**

* **RSI:** 65.34 (Slightly above neutral; neither overbought nor oversold)
* **PPO:** 0.26 (Positive, suggesting upward momentum)
* **Recent (20-day) Relative Divergence Change:**  NaN (-), indicating a short-term downward trend according to relative divergence (though NaN suggests missing data).  A clarification on the meaning of NaN in this context is needed for a more precise interpretation.
* **Expected Return:** 0.0% This indicates that the model currently predicts no outperformance relative to the S&P 500 over the long term (2+ years) based on provided data.  This prediction should be viewed with caution given the limited information and inherent uncertainty in long-term market forecasting.

**4. Recent Earnings Analysis:**

The provided earnings data shows some inconsistencies. There are duplicate entries for July 30, 2024.  Assuming the last entry for 2024-07-30 is correct:

* **Latest Quarterly Results:** Revenue and EPS show some volatility. Revenue fluctuated around $9 billion, while EPS ranged from $0.68 to $1.00.
* **Revenue Growth Trends:** Revenue growth is inconsistent, with some quarters showing growth and others showing decline.  A clearer trend cannot be determined without further analysis and more complete historical data.
* **EPS Trends:** Similar to revenue, EPS shows fluctuation with no clear consistent trend.
* **Beats or Misses:** Without access to analyst expectations, it is impossible to determine if any results were "beats" or "misses."

**5. Financial Information Analysis:**

* **Revenue and Profitability:** Revenue remained relatively stable around $9 billion during the reported period.  Profit margins fluctuated between 25% and 29%, indicating profitability but with some variability.
* **Capital and Profitability:** Negative equity values are concerning, indicating the company's liabilities exceed its assets.  Return on Equity (ROE) is also consistently negative, suggesting the company is not effectively generating returns on its invested capital.  This requires further investigation.

**6. News and Recent Issues:**

No recent news or market outlook information was provided.  The absence of analyst opinions further limits the depth of analysis.

**7. Overall Analysis:**

SBUX's performance has lagged the S&P 500 over the period analysed. While technical indicators suggest some short-term positive momentum, the negative equity and ROE values raise significant concerns about the company's financial health.  The inconsistent revenue and EPS growth, coupled with the lack of recent news and detailed analyst opinions, prevents a definitive conclusion about its future performance.  The negative expected return highlights the model's assessment of low long-term outperformance potential against the S&P 500, although this should be treated cautiously.  Further investigation into the negative equity and ROE, along with detailed analyst reports and up-to-date news, is strongly recommended before making any investment decisions.


**8. Disclaimer:**  This report is based solely on the limited data provided. It is not a recommendation to buy or sell SBUX stock and should not be considered financial advice.  Independent research and consultation with a financial advisor are essential before making investment decisions.
